We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+16.28%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.15B
AUM Growth
-$662M
Cap. Flow
-$1.16B
Cap. Flow %
-28%
Top 10 Hldgs %
45.63%
Holding
100
New
26
Increased
16
Reduced
28
Closed
28

Sector Composition

Rank Sector Weight
1 Healthcare 33.79%
2 Industrials 11.46%
3 Communication Services 10.72%
4 Consumer Discretionary 8.52%
5 Real Estate 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$163B
$323M 7.77%
5,130,951
-1,823,537
-26% -$109M
TMO icon
2
Thermo Fisher Scientific
TMO
$194B
$220M 5.3%
2,389,246
-127,990
-5% -$11.6M
HOT
3
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$211M 5.08%
3,174,135
+894,401
+39% +$59.2M
A icon
4
Agilent Technologies
A
$37.6B
$184M 4.44%
5,031,683
+1,325,303
+36% +$44.7M
TNL icon
5
Travel + Leisure Co
TNL
$4.69B
$176M 4.24%
6,395,254
-230,376
-3% -$6.31M
ETN icon
6
Eaton
ETN
$159B
$173M 4.17%
2,514,707
-2,038,496
-45% -$137M
DG icon
7
Dollar General
DG
$27.2B
$173M 4.17%
3,064,559
+730,539
+31% +$40.1M
CMI icon
8
Cummins
CMI
$91.6B
$168M 4.05%
1,263,988
-454,317
-26% -$56.1M
TWX
9
DELISTED
Time Warner Inc
TWX
$137M 3.31%
2,176,582
+867,683
+66% +$51.9M
PARA
10
DELISTED
Paramount Global Class B
PARA
$129M 3.1%
2,335,612
-694,531
-23% -$37M
CLVS
11
DELISTED
Clovis Oncology, Inc.
CLVS
$123M 2.97%
2,026,908
+1,452
+0.1% +$103K
HCA icon
12
HCA Healthcare
HCA
$83.1B
$114M 2.75%
2,669,424
-1,750,144
-40% -$68.4M
BIDU icon
13
Baidu
BIDU
$36.5B
$110M 2.66%
+710,399
New +$91.6M
ADBE icon
14
Adobe
ADBE
$89.3B
$106M 2.56%
+2,042,347
New +$97.4M
CAM
15
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$106M 2.55%
1,813,731
+1,336,273
+280% +$79.6M
WCRX
16
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
$104M 2.51%
4,538,824
+981,956
+28% +$20.8M
PFE icon
17
Pfizer
PFE
$143B
$99.2M 2.39%
3,638,863
-7,541,157
-67% -$205M
CRM icon
18
Salesforce
CRM
$136B
$90M 2.17%
1,733,775
+1,100,286
+174% +$49.9M
AMT icon
19
American Tower
AMT
$76.4B
$87.4M 2.11%
+1,179,417
New +$85.1M
MDCO
20
DELISTED
Medicines Co
MDCO
$79.3M 1.91%
+2,365,101
New +$75.3M
REGN icon
21
Regeneron Pharmaceuticals
REGN
$70.4B
$76M 1.83%
242,922
+188,357
+345% +$49.5M
AMZN icon
22
Amazon
AMZN
$2.63T
$70.3M 1.69%
4,497,840
+460,900
+11% +$6.87M
LOW icon
23
Lowe's Companies
LOW
$115B
$67.5M 1.63%
1,418,185
+22,712
+2% +$1.03M
TIBX
24
DELISTED
TIBCO SOFTWARE INC
TIBX
$58M 1.4%
2,265,712
+724,518
+47% +$17.3M
PCP
25
DELISTED
PRECISION CASTPARTS CORP
PCP
$52.7M 1.27%
+232,067
New +$52.4M

Similar funds

PFM Health Sciences's Q3 2013 Portfolio in Review

As of Q3 2013, PFM Health Sciences held 100 positions worth $4.15B, down 14% from $4.81B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

PFM Health Sciences withdrew a net $1.16B in Q3 2013, closing 28 positions and reducing 28 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $252M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 37% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Adobe worth $106M.

  • PFM Health Sciences's largest Q3 2013 buy was Adobe: 2,042,347 shares worth $106M.
  • PFM Health Sciences added most to CAMERON INTERNATIONAL CORPORATION in Q3 2013, an estimated $79.6M increase.
  • PFM Health Sciences's biggest Q3 2013 reduction was Pfizer, cutting an estimated $205M.
  • PFM Health Sciences fully exited Alphabet (Google) Class C in Q3 2013, selling an estimated $252M.
  • PFM Health Sciences's ten largest holdings make up 46% of its $4.15B portfolio in Q3 2013.
  • PFM Health Sciences opened 26 new positions and closed 28 in Q3 2013.
  • PFM Health Sciences's portfolio value fell 14% quarter-over-quarter to $4.15B.

Based on PFM Health Sciences's 13F filing for Q3 2013, filed 14 Nov 2013.